Cargando…
Angiopoietin-like protein 8 (betatrophin) may inhibit hepatocellular carcinoma through suppressing of the Wnt signaling pathway
OBJECTIVE(S): Hepatocellular carcinoma (HCC) is one of the leading fatal neoplasms and the most common primary liver malignancy worldwide. Peptide hormone ANGPTL8 (betatrophin) may act as an important regulator in HCC development through the Wnt/β-catenin pathway. We aimed to evaluate the effects of...
Autores principales: | Monzavi, Nastaran, Zargar, Seyed Jalal, Gheibi, Nematollah, Azad, Mahdi, Rahmani, Babak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885398/ https://www.ncbi.nlm.nih.gov/pubmed/31998458 http://dx.doi.org/10.22038/ijbms.2019.36612.8764 |
Ejemplares similares
-
Cloning, expression, and spectral analysis of mouse betatrophin
por: Gholami, Samaneh, et al.
Publicado: (2017) -
Anti proliferative and apoptotic effects on pancreatic cancer cell
lines indicate new roles for ANGPTL8 (Betatrophin)
por: Taherkhani, Fatemeh, et al.
Publicado: (2020) -
Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome
por: Abu-Farha, Mohamed, et al.
Publicado: (2016) -
Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice
por: Cox, Aaron R., et al.
Publicado: (2015) -
Angiopoietin‐like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non‐alcoholic fatty liver disease patients
por: Hong, Beverly S, et al.
Publicado: (2018)